T1	Participants 0 54	Recurrent tuberculosis in the United States and Canada
T2	Participants 440 645	a randomized study of two regimens for the last 4 months of treatment (n = 1,075) and a study of a twice-weekly rifabutin-containing regimen for human immunodeficiency virus-infected tuberculosis (n = 169)
#1	AnnotatorNotes T2	two regimes- one with n= 1075, and other n=169
